Lansdale, PA, United States of America

Arpi Hagopian



Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 222(Granted Patents)


Location History:

  • Clark, NJ (US) (1978 - 1980)
  • Sayreville, NJ (US) (1980 - 1983)
  • Lansdale, PA (US) (1989 - 1998)

Company Filing History:


Years Active: 1978-1998

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations in Vaccine Development by Arpi Hagopian

Introduction

Arpi Hagopian is a prominent inventor based in Lansdale, PA (US), known for her significant contributions to the field of vaccine development. With a total of 14 patents to her name, she has made remarkable strides in creating novel polysaccharide products that enhance vaccine efficacy.

Latest Patents

Her latest patents include a groundbreaking process for making capsular polysaccharides from Streptococcus pneumoniae. This innovative method produces type-specific capsular polysaccharide preparations that have an average of less than 1000 oligosaccharide repeat units per molecule. The resulting products exhibit polydispersities between 1.0 and 1.4, intrinsic viscosities between 0.6 and 3.0 dL/g, and less than 3% contamination by group-specific C-polysaccharide. These type-specific polysaccharides are particularly useful in the preparation of vaccines, especially covalent conjugates linked to T-cell stimulatory carrier proteins. Additionally, her work on a novel pneumococcal polysaccharide conjugate vaccine demonstrates the potential to prevent pneumococcal infections, especially in young children and infants who typically struggle to mount a protective immune response.

Career Highlights

Arpi Hagopian is currently employed at Merck & Company, Inc., where she continues to innovate in the field of immunology. Her extensive research and development efforts have positioned her as a leader in vaccine technology, contributing to public health advancements.

Collaborations

Throughout her career, Arpi has collaborated with esteemed colleagues such as Peter J. Kniskern and Dennis J. Carlo, further enhancing the impact of her work in the scientific community.

Conclusion

Arpi Hagopian's contributions to vaccine development through her innovative patents and collaborative efforts underscore her vital role in advancing medical science. Her work not only addresses critical health challenges but also paves the way for future innovations in immunization strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…